BOT 3.75% 41.5¢ botanix pharmaceuticals ltd

Ann: Trading Halt, page-191

  1. 3,063 Posts.
    lightbulb Created with Sketch. 1580
    Exactly this.
    The reality is that BOT have received material information from the FDA. Now if this was a straight up rejection, why did they not just release straight to market? For the ASX actually requires that interruptions to trading be kept at a minimum, so BOT would have to release immediately.
    However a TH has been requested, which means they have material info - but can’t release immediately for some reason. It seems the ASX agreed with BOT since they approved a TH (no the ASX does not need to approve a TH and will only do this in agreement with company - they will not give a TH just to build anticipation or for the company just to release at appropriate time for them etc)

    Now what is this situation? Could be outstandingly positive and could be negative and anything in between.

    Could be
    … on approval we have accepted T/O BOD need to get together and hash out detail as before accpeting offer
    …FDA requires some more stuff (just little things) from BOT before date of approval.
    …and various other scenarios in between

    DYOr and all that
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
41.5¢
Change
0.015(3.75%)
Mkt cap ! $751.1M
Open High Low Value Volume
39.5¢ 42.8¢ 39.3¢ $5.876M 14.27M

Buyers (Bids)

No. Vol. Price($)
3 252500 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
41.5¢ 78414 1
View Market Depth
Last trade - 16.10pm 02/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.